Motif Labs successfully launched a new production line, servicing Canada’s growing Cannabinol (CBN) market. Employing a proprietary process to produce high purity CBN at scale, wholesale and brand partners of Motif can now develop unique and differentiated CBN products and bring them to market quickly, with a compelling value proposition.
“We receive inquiries about CBN on a weekly basis” noted Motif’s chief revenue officer, Mandy Kang. “Adding CBN to our existing production capabilities is an exciting milestone for the company, and further increases the suite of products and services we provide our valued customers. With our steadfast commitment to efficiency, quality and customer service, our clients are excited to launch unique products that are in high demand. From ideation through to packaged product, Motif will be there every step of the way.”
Motif Labs expects significant demand for its CBN production capacity, with products slated to hit store shelves starting in Q2 2022.
Related News
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.